You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 104 No. 1, January 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Retina S Antigen-Induced Uveitis

The Efficacy of Cyclosporine and Corticosteroids in Treatment

Gerald Striph, MD; Bernard Doft, MD; Bruce Rabin, MD, PhD; Bruce Johnson, MD

Arch Ophthalmol. 1986;104(1):114-117.


Abstract

• This study compares the efficacy of cyclosporine and corticosteroids in the treatment of retina S antigen-induced uveitis (experimental autoimmune uveitis). Forty guinea pigs were immunized with retina S antigen in complete Freund's adjuvant to induce uveitis. After 16 days, animals were divided into groups that received a two-week course of daily intramuscular injections of cyclosporine, corticosteroids, both drugs, or saline. Eyes were graded by a masked retinal specialist for amount of vitreous cells by biomicroscopy, and after enucleation by a masked ocular pathologist for histologic evidence of inflammation. Clinically and histopathologically, animals treated with cyclosporine, or cyclosporine and corticosteroids, had statistically significant reduction of intraocular inflammation compared with controls. Corticosteroids alone had a less beneficial effect. The combined use of cyclosporine and corticosteroids, at the single dose tested, did not demonstrate synergism.



Author Affiliations

From the Retina-Vitreous Consultants (Dr Doft) and the Departments of Ophthalmology (Drs Doft and Striph) and Pathology (Drs Johnson and Rabin), University of Pittsburgh School of Medicine and Eye and Ear Hospital. Dr Striph is now with the Department of Ophthalmology, Washington University Medical Center, St Louis.


Footnotes

Accepted for publication Sept 9, 1985.

Presented in part as a scientific exhibition at the annual meeting of the American Academy of Ophthalmology, Atlanta, Nov 11-15, 1984.

Reprint requests to Retina-Vitreous Consultants, Eye and Ear Hospital, 230 Lothrop St, Pittsburgh, PA 15213 (Dr Doft).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of a Delivery System Providing Long-term Release of Cyclosporine
Pearson et al.
Arch Ophthalmol 1996;114:311-317.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.